Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Left ventricular insufficiency: systolic versus diastolic dysfunction]

M Federmann¹, B Risti, O M Hess

¹Departement für Innere Medizin, Kardiologie, Universitätsspital Zürich.

Schweizerische Medizinische Wochenschrift

|July 2, 1994

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Is resting heart rate a cardiovascular risk factor?].

Praxis·2008

Same author

ECG-triggered skeletal muscle stimulation improves hemodynamics and physical performance of heart failure patients.

The International journal of artificial organs·2008

Same author

ECG-triggered muscular counterpulsation for treatment of low cardiac output.

The International journal of artificial organs·2007

Same author

Improved neo-endothelialization of small diameter ePTFE grafts with titanium coating.

The International journal of artificial organs·2007

Same author

Homocysteine and B vitamins.

Handbook of experimental pharmacology·2006

Same author

PPS-PEG surface coating to reduce thrombogenicity of small diameter ePTFE vascular grafts.

The International journal of artificial organs·2005

Same journal

Respiratory function test in the case of temporary phrenic nerve contusion, associated with pneumoperitoneum; About the diagnostic value of laparoscopy.

Schweizerische medizinische Wochenschrift·2010

Same journal

Treatment of pulmonary tuberculosis and pleurisy by means of temporary paralysis of the diaphragm, supported by the pneumoperitoneum.

Schweizerische medizinische Wochenschrift·2010

Same journal

Boeck's disease as a tuberculous syndrome.

Schweizerische medizinische Wochenschrift·2010

Same journal

Enteral primary tubercular complexes

Schweizerische medizinische Wochenschrift·2010

Same journal

Tuberculous stenoses of the large bronchi.

Schweizerische medizinische Wochenschrift·2010

Same journal

About the enzyme action.

Schweizerische medizinische Wochenschrift·2010

See all related articles

Left ventricular failure presents as systolic dysfunction (poor prognosis) or diastolic dysfunction (better prognosis). Treatments differ, with ACE-inhibitors for systolic and calcium channel blockers for diastolic dysfunction.

Area of Science:

Cardiology
Internal Medicine
Heart Failure Pathophysiology

Background:

Left ventricular failure is categorized into systolic pump failure (systolic dysfunction) and diastolic filling failure (diastolic dysfunction).
Understanding the distinct clinical patterns and prognoses of these conditions is crucial for effective heart failure management.

Observation:

Systolic dysfunction is characterized by left ventricular failure, cardiomegaly, and reduced ejection fraction.
Diastolic dysfunction presents with pulmonary congestion, a normal or mildly enlarged ventricle, and preserved ejection fraction.

Findings:

Systolic dysfunction has a poorer prognosis (40% 5-year survival) compared to isolated diastolic dysfunction (70% 5-year survival).
Treatment for systolic dysfunction involves ACE-inhibitors, diuretics, digitalis, low-dose beta-blockers, and spironolactone.

Related Experiment Videos

Diastolic dysfunction management prioritizes calcium channel blockers for improved relaxation and filling, with ACE-inhibitors for hypertensive heart disease; diuretics and beta-blockers are second-line, and digitalis is contraindicated.

Implications:

Differentiating between systolic and diastolic dysfunction is essential for tailoring appropriate medical interventions.
Targeted pharmacotherapy based on the type of ventricular dysfunction can significantly improve patient outcomes and survival rates.
Further research into optimizing treatment strategies for both forms of left ventricular failure is warranted.